| Comfortis |
Veterinary |
spinosad |
spinosad |
EMEA/V/C/002233 |
Elanco GmbH |
2011/02/11
|
Withdrawn |
| Fluenz |
Human |
influenza vaccine (live attenuated, nasal) |
reassortant influenza virus (live attenuated) of the following strains:A/California/7/2009 (H1N1)pdm09 like strain, A/Victoria/361/2011 (H3N2) like strain, B/Massachusetts/2/2012 like strain |
EMEA/H/C/001101 |
MedImmune LLC |
2011/01/27
|
Withdrawn |
| Iasibon |
Human |
ibandronic acid |
ibandronic acid |
EMEA/H/C/002025 |
Pharmathen S.A. |
2011/01/21
|
Authorised |
| Docetaxel Teva Pharma |
Human |
docetaxel |
docetaxel |
EMEA/H/C/002032 |
Teva Pharma B.V. |
2011/01/21
|
Lapsed |
| Potactasol |
Human |
topotecan |
topotecan |
EMEA/H/C/002282 |
Actavis Group PTC ehf |
2011/01/06
|
Authorised |
| BTVPUR AlSap 1 |
Veterinary |
bluetongue-virus serotype-1 antigen |
bluetongue-virus serotype-1 antigen |
EMEA/V/C/002230 |
Merial |
2010/12/17
|
Withdrawn |
| Brilique |
Human |
ticagrelor |
ticagrelor |
EMEA/H/C/001241 |
AstraZeneca AB |
2010/12/03
|
Authorised |
| Possia |
Human |
ticagrelor |
ticagrelor |
EMEA/H/C/002303 |
AstraZeneca AB |
2010/12/03
|
Withdrawn |
| Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics |
Human |
prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) |
influenza virus surface antigens (haemagglutinin and neuraminidase) of strain A/Viet Nam/1194/2004 (H5N1) |
EMEA/H/C/002269 |
Novartis Vaccines and Diagnostics S.r.l. |
2010/11/29
|
Expired |
| Leflunomide ratiopharm |
Human |
leflunomide |
leflunomide |
EMEA/H/C/002035 |
Ratiopharm GmbH |
2010/11/28
|
Authorised |
| Aflunov |
Human |
zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) |
influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23) |
EMEA/H/C/002094 |
Seqirus S.r.l. |
2010/11/28
|
Authorised |
| BTVPUR AlSap 2-4 |
Veterinary |
inactivated adjuvanted vaccine against bluetongue virus serotype 2 and 4 infections |
bluetongue-virus serotype-2 antigen;bluetongue-virus serotype-4 antigen |
EMEA/V/C/000139 |
Mérial |
2010/11/04
|
Withdrawn |
| Ruconest |
Human |
conestat alfa |
recombinant human C1-inhibitor |
EMEA/H/C/001223 |
Pharming Group N.V. |
2010/10/28
|
Authorised |
| Clopidogrel HCS |
Human |
clopidogrel |
clopidogrel (as hydrochloride) |
EMEA/H/C/002255 |
HCS bvba |
2010/10/28
|
Authorised |
| Clopidogrel Teva Generics B.V. |
Human |
clopidogrel |
clopidogrel (as hydrochloride) |
EMEA/H/C/002254 |
Teva Pharma B.V. |
2010/10/28
|
Lapsed |
| Twynsta |
Human |
telmisartan;amlodipine |
telmisartan;amlodipine |
EMEA/H/C/001224 |
Boehringer Ingelheim International GmbH |
2010/10/07
|
Authorised |
| Myclausen |
Human |
mycophenolate mofetil |
mycophenolate mofetil |
EMEA/H/C/001218 |
Passauer Pharma GmbH |
2010/10/07
|
Authorised |
| Telmisartan Actavis |
Human |
telmisartan |
telmisartan |
EMEA/H/C/001168 |
Actavis Group PTC ehf |
2010/09/29
|
Authorised |
| Ibandronic Acid Teva |
Human |
ibandronic acid |
ibandronic acid |
EMEA/H/C/001195 |
Teva Pharma B.V. |
2010/09/17
|
Authorised |
| Rapiscan |
Human |
regadenoson |
regadenoson |
EMEA/H/C/001176 |
GE Healthcare AS |
2010/09/06
|
Authorised |